Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026

Summary by AI BETAClose X

Vivoryon Therapeutics N.V. announced that it will report its full year 2025 financial results and provide business updates on April 23, 2026. The company, which is developing small molecule medicines for inflammatory and fibrotic disorders, particularly kidney diseases, will host a public conference call and webcast to discuss these updates. The full year 2025 financial results will be available for download on the company's website prior to the call.

Disclaimer*

UK 100

Latest directors dealings